Zacks Investment Research on MSN
Teva's Q4 earnings beat, branded drugs drive revenue growth
Teva Pharmaceutical Industries TEVA reported fourth-quarter 2025 adjusted earnings of 96 cents per share, which ...
The headline numbers for Teva Pharmaceutical Industries (TEVA) give insight into how the company performed in the quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results